Adult pertussis in the pre-and post-vaccine eras: Lifelong vaccine-induced immunity?

Expert Review of Vaccines

Volumn 13, Issue 9, 2014, Pages 1073-1080

  Cherry, James D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adult; Bordetella pertussis; immunity; pertussis; vaccine

Indexed keywords

PERTUSSIS VACCINE;

ADULT DISEASE; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); HISTORY OF MEDICINE; HUMAN; INFECTION RATE; LABORATORY DIAGNOSIS; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; VACCINATION; ADULT; AGE; BORDETELLA PERTUSSIS; IMMUNOLOGY; INCIDENCE; PREVALENCE; TIME; WHOOPING COUGH;

ADULT; AGE FACTORS; BORDETELLA PERTUSSIS; HUMANS; INCIDENCE; PERTUSSIS VACCINE; PREVALENCE; TIME FACTORS; WHOOPING COUGH;

EID: 84905967879     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.935765     Document Type: Review

References (79)

1. 2012 Final pertussis surveillance report. Centers for Disease Control and Prevention, 2014. Available from: www.cdc.gov/pertussis/surv-reporting.html [Last accessed 24 February 2014]
2. Health Protection Agency (HPA). Incidence of laboratory-confirmed pertussis, by total case-patients and age group in England and Wales, 1998-2012. HPA: London. Available from: www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/ 1317135453069 [Last accessed 4 September 2012]
3. Allen A. Public health. The pertussis paradox. Science 2013;341:454-5
4. Centers for Disease Control and Prevention. Pertussis epidemic-Washington, 2012. MMWR Morb Mortal Wkly Rep 2012;61: 517-22
5. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115:1422-7 (Pubitemid 43852794)
6. Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. N Engl J Med 2012;367:785-7
7. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013;9: e1003418
8. Cherry JD, Heininger U. Pertussis and other bordetella infections. In: Cherry JD, Harrison GJ, Kaplan SJ, Steinbach WJ, Hotez P, editors. Feigin and Cherry's, Textbook of Pediatric infectious diseases. 7th ed. Elsevier/Saunders; 2014. p. 1616-39
9. Spokes PJ, Quinn HE, McAnulty JM. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull 2010;21: 167-73
10. van der Maas NA, Mooi FR, de Greeff SC, et al. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine 2013;31:4541-7
11. van Hoek AJ, Campbell H, Amirthalingam G, et al. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Euro Surveill 2013;18:9
12. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012;161:1091-6
13. Fabianva K, Benes C, Kriz B. A steady rise in incidence of pertussis since nineties in the Czech Republic. Epidemiol Mikrobiol Imunol 2010;59:25-3
14. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1988. MMWR Morb Mortal Wkly Rep 1989;37:1-57
15. Cherry JD. Pertussis and immunizations: facts, myths, and misconceptions. 2014. Available from: http://californiapediatrician. org/pertussis-and- immunizations-factsmyths-and-misconceptions/
16. Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012;129:968-70
17. Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014;21:119-25
18. Schmidtke AJ, Boney KO, Martin SW, et al. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis 2012;18: 1248-55
19. Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013;6:787-96
20. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail. Prevent infection and transmission in a nonhuman primate
21. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-9 (Pubitemid 40824285)
22. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007;26:238-42 (Pubitemid 46340771)
23. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18: 326-82 (Pubitemid 40548297)
24. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26: 293-9 (Pubitemid 46596651)
25. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999;28(Suppl 2): S112-17 (Pubitemid 29270379)
26. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999;28(Suppl 2): S107-11 (Pubitemid 29270378)
27. Holt LE. The diseases of infancy and childhood: for the use of students and practitioners of medicine. D Appleton; New York: 1902. p. 985-96
28. Luttinger P. The epidemiology of pertussis. Am J Dis Child 1916;12:290-315
29. Collins DC. Age incidence of the common communicable diseases of children: a study of case rates among all children and among children not previously attacked and of death rates and the estimated case fatality. Public Health Rep 1929;44: 763-827
30. Friedlander A. Whooping cough. In: Abt IA, editors. Pediatrics. W.B Saunders; Philadelphia: 1925. p. 128-47
31. Lapin JH. Whooping cough. Charles Thomas; Springfield, IL, USA: 1943.
32. Madsen T. Whooping cough: its bacteriology, diagnosis, prevention and treatment. Boston M & S J; 1925. 192: 50-60
33. Mannderstedt G. Pertussis in adults. J Pediatr 1934;5:596-600
34. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000;182:174-9 (Pubitemid 30497802)
35. Schmitt-Grohe S, Cherry JD, Heininger U, et al. Pertussis in German adults. Clin Infect Dis 1995;21:860-6
36. Wirsing von Knig CH, Postels-Multani S, et al. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:1326-9
37. Postels-Multani S, Schmitt HJ, Wirsing von Konig CH, et al. Symptoms and complications of pertussis in adults. Infection 1995;23:139-42
38. Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14: 464-71
39. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-9 (Pubitemid 32337117)
40. Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010;51:663-7
41. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006;55:1-37
42. Mertens PL, Stals FS, Schellekens JF, et al. An epidemic of pertussis among elderly people in a religious institution in The Netherlands. Eur J Clin Microbiol Infect Dis 1999;18:242-7 (Pubitemid 29527968)
43. Ridda I, Yin JK, King C, et al. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine 2012;30: 6745-52
44. Gil A, Oyaguez I, Carrasco P, Gonzalez A. Hospital admissions for pertussis in Spain, 1995-1998. Vaccine 2001;19:4791-4 (Pubitemid 32800765)
45. Nakamura Y, Kamachi K, Toyoizumi-Ajisaka H, et al. Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect 2011;17:365-70
46. Cherry JD, Tan T, Wirsing von Konig CH, et al. Clinical definitions of pertussis: summary of a global pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012;54:1756-64
47. de Melker HE, Versteegh FG, Schellekens JF, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006;53:106-13 (Pubitemid 44028673)
48. Versteegh FG, Mertens PL, de Melker HE, et al. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 2005;133:737-48 (Pubitemid 41015566)
49. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994;169:1297-305 (Pubitemid 24164594)
50. Yih WK, Lett SM, des Vignes FN, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-16
51. Guiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011;30:307-12
52. He Q, Barkoff AM, Mertsola J, et al. High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill. 2012;17:32
53. Prince HE, Lape-Nixon M, Matud J. Evaluation of a tetraplex microsphere assay for Bordetella pertussis anitbodies. Clin Vaccine Immunol 2006;13:266-70 (Pubitemid 43383797)
54. Prince HE, Lieberman JM, Cherry JD. Age-related differences in patterns of increased Bordetella pertussis antibodies. Clin Vaccine Immunol 2012;19:545-50
55. Holmes WH. Chapter 24 Whooping-cough, or pertussis. In: Bacillary and rickettsial infections acute and chronic, a textbook: black death to white plague. Macmillan; New York: 1940. 394-414
56. Fales WT. The age distribution of whooping cough, measles, chicken pox, scarlet fever, and diphtheria in various areas in the United States. Am J Hyg 1928;8:759-99
57. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984;14:1-78
58. Gordon JE, Hood RI. Whooping cough and its epidemiological anomalies. Am J Med Sci 1951;222:333-61
59. http://ncirs.edu/au/news/Pertussis-Workshop-Booklet-FInal-25-26Aug11.pdf [Last accessed 18 August 2011]
60. Sweden TPHAo. Laboratory reported pertussis cases in Sweden 1986-2012. Folkhälsomyndigheten/The Public Health Agency of Sweden. Available from: www. folkhalsomyndigheten.se
61. Deville JG, Cherry JD, Christenson PD, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995;21:639-42
62. Ward JI, Cherry JD, Chang SJ, et al. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin Infect Dis 2006;43:151-7
63. Hodder SL, Cherry JD, Mortimer EA Jr, et al. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 2000;31:7-14 (Pubitemid 32268930)
64. Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4 (Pubitemid 26175816)
65. Cherry JD, Heininger U, Stehr K, Christenson P. The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics 1998;102:909-12 (Pubitemid 28462533)
66. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-63 (Pubitemid 41434634)
67. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:S58-61 (Pubitemid 40676539)
68. Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982;1:666-9 (Pubitemid 12179942)
69. Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:1211-19
70. Cherry JD, Beer T, Chartrand SA, et al. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men. Clin Infect Dis 1995;20:1271-4
71. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16:1901-6 (Pubitemid 28473933)
72. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-16 (Pubitemid 28473934)
73. Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012;367:1012-19
74. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012;54: 1730-5
75. Baxter R, Bartlett J, Rowhani-Rahbar A, et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013;347:f4249
76. Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013;131:e1716-22
77. Koepke R, Eickhoff JC, Ayele RA, et al. Using an immunization information system to estimate the effectiveness of Tdap in preventing pertussis during a large outbreak, Wisconsin, 2012. Presented at IDWeek. San Francisco 2-6 October 2013
78. Guerra FA, Blatter MM, Greenberg DP, et al. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Pediatrics 2009;123:301-12
79. Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 2004;190: 535-44